Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early sequential multi-dose oral tranexamic acid for perioperative blood loss in hip fracture surgery
ChiCTR2000032836Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tranexamic acid in hip fracture (2 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoints: total blood loss, hidden blood loss and 3 more. Started May 2020; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
hip fracture
Beyond the preview
Go deeper on ChiCTR2000032836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032836.